Avidity Biosciences

Filed a patent for "compositions and methods of using prkag2-targeting antibody-oligonucleotide conjugates" on Tue, June 27, 2023

Filed a patent for "compositions and methods of using pln-targeting antibody-oligonucleotide conjugates" on Fri, June 30, 2023

Filed a patent for "conjugate compositions comprising phosphoryl guanidine linkages and uses thereof" on Fri, June 2, 2023

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, September 19, 2024

Filed a patent for "una amidites and uses thereof" on Thu, September 12, 2024

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, August 29, 2024

Filed a patent for "compositions and methods of treating muscle atrophy and myotonic dystrophy" on Thu, February 16, 2023

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, March 23, 2023

Filed a patent for "compositions and methods of treating muscle atrophy and myotonic dystrophy" on Thu, June 29, 2023

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, September 7, 2023

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, September 14, 2023

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, October 26, 2023

Filed a patent for "compositions and methods of treating pompe disease" on Thu, October 19, 2023

Filed a patent for "compositions and methods of treating muscle atrophy and myotonic dystrophy" on Thu, June 29, 2023

Filed a patent for "nucleic acid-polypeptide compositions and uses thereof" on Thu, July 27, 2023

Filed a patent for "anti-transferrin receptor antibody-pmo conjugates for inducing dmd exon 44 skipping" on Thu, November 16, 2023

Filed a patent for "compositions and methods of treating muscle dystrophy" on Thu, December 14, 2023

Filed a patent for "anti-transferrin receptor antibodies and uses thereof" on Thu, April 25, 2024

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, April 25, 2024

Filed a patent for "compositions and methods of treating facioscapulohumeral muscular dystrophy" on Thu, April 18, 2024

Filed a patent for "antibody oligonucleotide conjugate compositions and methods of inducing dmd exon 44 skipping" on Tue, April 5, 2022

Filed a patent for "nucleic acid-polypeptide compositions and methods of inducing exon skipping" on Thu, October 6, 2022

Filed a patent for "compositions and methods of treating muscle dystrophy" on Thu, December 29, 2022